Lozano M, Cid J
Curr. Opin. Hematol.. 2013 Nov;20(6):540-5, PMID: 24104416
In the past 20 years, several pathogen inactivation technologies have been developed to be applied to blood components. This review is intended to summarize the data currently available about the technologies and the clinical use of products inactivated by those techniques.
HEMATOLOGY